Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …

Simple Summary Intrahepatic cholangiocarcinoma is an aggressive primary liver cancer
originating in the intrahepatic bile ducts. While surgical resection is the only curative …

Biliary anatomic variations are usually asymptomatic, but they may cause problems in
diagnostic investigations and interventional and surgical procedures, increasing both their …

Objectives: Identify patients with possible intra-or extrahepatic cholangiocarcinoma based
on their clinical presentation. Select an appropriate diagnostic strategy for a patient with …

Simple Summary Primary liver cancer is the third most common cause of cancer-related
deaths worldwide. Risk factors for primary liver cancer include chronic viral hepatitis B and C …

Cholangiocarcinoma is a lethal malignancy of the biliary epithelium that can arise anywhere
along the biliary tract. Surgical resection confers the greatest likelihood of long‐term …

Among patients with downsized/downstaged disease, 31% had an R0 resection, and 67%
had an R1 resection.[2] In another study, 36% of patients with iCCA were able to be …

Purpose To investigate the overall efficacy and survival profile of yttrium-90 (90 Y)
radioembolization for unresectable intrahepatic cholangiocarcinoma (ICC). Materials and …

Simple Summary Our current ability to treat cholangiocarcinoma is limited. Surgery to
remove the tumor is only possible in a small proportion of cases of the disease due to the …

Background: Systemic chemotherapy (SC) remains the only first-line treatment for
unresectable intrahepatic cholangiocarcinoma (iCCA). Hepatic arterial infusion …